Mereo BioPharma Group PLC (MREO)
3.53
-0.29
(-7.59%)
USD |
NASDAQ |
Nov 15, 16:00
3.525
0.00 (0.00%)
After-Hours: 20:00
Mereo BioPharma Group Research and Development Expense (TTM): 16.91M for Sept. 30, 2024
Research and Development Expense (TTM) Chart
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| September 30, 2024 | 16.91M |
| June 30, 2024 | 17.34M |
| Date | Value |
|---|---|
| March 31, 2024 | 16.10M |
| December 31, 2023 | 17.42M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
16.10M
Minimum
Mar 2024
17.42M
Maximum
Dec 2023
16.94M
Average
17.13M
Median
Research and Development Expense (TTM) Benchmarks
| NuCana PLC | 35.08M |
| TC BioPharm (Holdings) PLC | -- |
| Biodexa Pharmaceuticals PLC | -- |
| Adaptimmune Therapeutics PLC | 143.17M |
| Bicycle Therapeutics PLC | 167.88M |